GW Pharma denies supply issues with marijuana-based drug Epidiolex after stock falls

GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply issues related to the cannabis-derived drug after a tweet from a patient’s father complained he could not source the medicine. GW’s stock was down more than 3% on Wednesday on the Nasdaq after the tweet from San […]

GW Pharma denies supply issues with marijuana-based drug Epidiolex after stock falls is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs